相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
Charles L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications
Zongzhong Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy
Satoru Kase et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Transplant reno-vascular stenoses associated with early erythropoeitin use
Suja Nagarajan et al.
CLINICAL TRANSPLANTATION (2007)
Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo
C. M. Logar et al.
KIDNEY INTERNATIONAL (2007)
The paradox of dysfunctional high-density lipoprotein
Benjamin J. Ansell et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury
Jan Menne et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
Arintaya Phrommintikul et al.
LANCET (2007)
Target level for hemoglobin correction in patients with diabetes and CKD: Primary results of the anemia correction in diabetes (ACORD) study
Eberhard Ritz et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Molecular control of iron transport
Tomas Ganz
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Anti hypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin
Marcel Lebel et al.
AMERICAN JOURNAL OF HYPERTENSION (2006)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
Tilman B. Drueke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice
K Satoh et al.
CIRCULATION (2006)
Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model
E Spandou et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment variables updated over time
BM Robinson et al.
KIDNEY INTERNATIONAL (2005)
Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD
A Levin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury
I Yatsiv et al.
FASEB JOURNAL (2005)
Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease
PS Parfrey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats
ME Rodrique et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2005)
Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients
S Kahraman et al.
NEPHROLOGY (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Erythropoietin increases asymmetric dimethylarginine in endothelial cells:: Role of dimethylarginine dimethylaminohydrolase
F Scalera et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002
RA Wolfe et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure
CS Lim et al.
KIDNEY INTERNATIONAL (2004)
Association of kidney function and hemoglobin with left ventricular morphology among African Americans: The Atherosclerosis Risk in Communities (ARIC) Study
BC Astor et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Erythropoietin protects against ischaemic acute renal injury
DA Vesey et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients
SY Li et al.
KIDNEY INTERNATIONAL (2004)
Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial
C Gouva et al.
KIDNEY INTERNATIONAL (2004)
Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury
P van der Meer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (Stage 3 or 4): Results of a randomized clinical trial
SD Roger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia
M Abdelrahman et al.
SHOCK (2004)
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
F Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Cardioprotective effects of erythropoietin in the reperfused ischemic heart - A potential role for cardiac fibroblasts
CJ Parsa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A novel protective effect of erythropoietin in the infarcted heart
CJ Parsa et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats
C Moon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
L Calvillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Relationship between eicosanoids and endothelin-1 in the pathogenesis of erythropoietin-induced hypertension in uremic rats
ME Rodrigue et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron
DS Silverberg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
J Himmelfarb et al.
KIDNEY INTERNATIONAL (2002)
Tissue factor and thrombomodulin in hemodialysis patients: Associations with endothelial injury, liver disease, and erythropoietin therapy
J Borawski et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2002)
Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study
WM McClellan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Cardiovascular effects of erythropoietin and anemia correction
ND Vaziri
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2001)
Activation of the transcription factor NF-κB by the erythropoietin receptor -: Structural requirements and biological significance
T Bittorf et al.
CELLULAR SIGNALLING (2001)
Association of angiotensinogen gene polymorphism with erythropoietin-induced hypertension: a preliminary report
S Kuriyama et al.
HYPERTENSION RESEARCH (2001)
Involvement of erythropoietin-induced cytosolic free calcium mobilization in activation of mitogen-activated protein kinase and DNA synthesis in vascular smooth muscle cells
T Akimoto et al.
JOURNAL OF HYPERTENSION (2001)
分享论文
